17 June 2021

Oxford PharmaGenesis named in Medical Marketing and Media’s Agency 100 report

Media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in the latest Agency 100 – the annual definitive ‘who’s who’ ranking of the sector’s top healthcare marketing firms in North America.

  • All
  • News
  • Articles
  • Events

Learning at Work Week: Oxford PharmaGenesis boosts colleagues' skills

Oxford PharmaGenesis continues to boost colleagues’ skills and expertise through a wide range of professional and personal development sessions offered to celebrate Learning at Work Week 2021 (17–23 May).

2021 Clinical Data Disclosure, Transparency and Plain Language Summaries

Monday 10 May to Wednesday 12 May A focus of the 2021 Clinical Data Disclosure, Transparency and Plain Language Summaries virtual conference was on the forthcoming implementation of the EU Clinical Trial Regulation (EU CTR) and the launch of the Clinical Trial Information Service (CTIS).  However, the important role of different forms of plain language […]

Kidney disease consensus manuscript published: highlights the need to improve awareness of racial health disparities

Oxford PharmaGenesis is proud to announce the publication of a Delphi consensus manuscript in the Journal of the American Society of Nephrology. The publication highlights the need to increase awareness among key stakeholders of racial health disparities in kidney disease and of APOL1-associated nephropathy.

Oxford PharmaGenesis creates new Director of Innovation role and makes first appointments

Oxford PharmaGenesis has made its first appointments to the new role of Director of Innovation, created specifically to support teams across the global organization in utilizing new and emerging technology to support their clients’ unmet needs.

Support for colleagues earns Oxford PharmaGenesis a Great Place to Work® Excellence in Wellbeing 2021‒2022 award

Oxford PharmaGenesis has been designated a centre of Excellence in Wellbeing this year by Great Place to Work®. The accolade recognizes organizations with excellent well-being practices and is a welcome acknowledgement of our increasing efforts to foster a culture of openness, empowerment and support in the workplace.

Emerging trends in AI: COO Richard White participates in the FNLM workshop

Richard White, COO of Oxford PharmaGenesis, was a panellist at the recent virtual workshop on ‘Artificial intelligence (AI) to accelerate discovery’, hosted by the Friends of the National Library of Medicine (FNLM) and sponsored by Oxford PharmaGenesis. He discussed emerging trends in the use of AI by the pharmaceutical industry, with a focus on how […]